214
Views
28
CrossRef citations to date
0
Altmetric
Original Research

Adjuvant endocrine therapy after breast cancer: a qualitative study of factors associated with adherence

, , , , , , , , & show all
Pages 291-300 | Published online: 16 Feb 2018

References

  • World Health Organization (WHO)Adherence to long term therapies: evidence for action [online]2014 Available from: http://apps.who.int/iris/bitstream/10665/42682/1/9241545992.pdfAccessed March 5, 2016
  • Cancer Research UKCancer Statistics Reports for the UK2016 Available from: http://www.cancerresearchuk.org/about-cancer/what-is-cancer/understanding-cancer-statistics-incidence-survival-mortalityAccessed August 14, 2016
  • WilkingtonLPatterns of Breast Cancer Recurrence and Associated Health Care Costs of 1000 Patients Treated in Leeds: A Longitudinal StudyUKNational Cancer Intelligence Network2012
  • DowsettMCuzickJIngleJMeta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifenJ Clin Oncol201028350951819949017
  • GossPJIngleNPritchardKIA randomized trial (MA.17R) of extending adjuvant letrozole for 5 years after completing an initial 5 years of aromatase inhibitor therapy alone or preceded by tamoxifen in postmenopausal women with early-stage breast cancerJ Clin Oncol201634suppl abstrLBA1
  • DaviesCPanHGodwinJAdjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative GroupLong-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trialLancet2013381986980581623219286
  • GossPEIngleJNMartinoSRandomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17J Natl Cancer Inst200597171262127116145047
  • HowellACuzickJBaumMATAC Trialists’ GroupResults of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years’ adjuvant treatment for breast cancerLancet20053659453606215639680
  • GrayR10 years of tamoxifen better than 5 in reducing breast cancer recurrence and deathJ Clin Oncol201432212255226924868023
  • MurphyCCBartholomewLKCarpentierMYBluethmannSMVernonSWAdherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic reviewBreast Cancer Res Treat2012134245947822689091
  • MakubateBDonnanPTDewarJAThompsonAMMcCowanCCohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortalityBr J Cancer201310871515152423519057
  • McCowanCShearerJDonnanPTCohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancerBr J Cancer200899111763176818985046
  • McCowanCWangSThompsonAMMakubateBPetrieDJThe value of high adherence to tamoxifen in women with breast cancer: a community-based cohort studyBr J Cancer201310951172118023949153
  • BrettJFenlonDBoultonMFactors associated with intentional and unintentional non-adherence to adjuvant endocrine therapy following breast cancerEur J Cancer Care (Engl) Epub2016113010.1111/ecc.12601
  • CahirCGuinanEDombrowskiSUSharpLBennettKIdentifying the determinants of adjuvant hormonal therapy medication taking behaviour in women with stages IIII breast cancer: a systematic review and meta-analysisPatient Educ Couns2015981215241539
  • MoonZMoss-MorrisRHunterMSCarlisleSHughesLDBarriers and facilitators of adjuvant endocrine therapy adherence and persistence in women with breast cancer: a systematic reviewPatient Prefer Adherence20171130532228260867
  • HarrowADrydenRMcCowanCA hard pill to swallow: a qualitative study of women’s experiences of adjuvant endocrine therapy for breast cancerBMJ Open201446e005285
  • CahirCDombrowskiSUKellyCMKennedyMJBennettKSharpLWomen’s experiences of hormonal therapy for breast cancer: exploring influences on medication-taking behaviourSupport Care Cancer201523113115313025744290
  • McGinnisBOlsonKLMagidDFactors related to adherence to statin therapyAnn Pharmacother200741111805181117925498
  • RitchieJSpencerLQualitative data analysis for applied policy researchBrymanABurgessRAnalyzing Qualitative DataLondonRoutledge1993173194
  • HorneRChapmanSParhamRFreemantleNForbesACooperVUnderstanding patients’ adherence-related beliefs about medicines prescribed for long term condition: a meta-analytic review of the necessity-concerns frameworkPLoS One2013812e8063324312488
  • HorneRHankinsMWeinmanJThe beliefs about Medicines Questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medicationPsychol Health199914124
  • CarterSRMolesRWhiteLChenTFMedication information seeking behavior of patients who use multiple medicines: how does it affect adherencePatient Educ Couns2013921748023433733
  • WoutersHStiggelboutAMBouvyMLEndocrine therapy for breast cancer: assessing an array of women’s treatment experiences and perceptions, their perceived self-efficacy and non-adherenceClin Breast Cancer2014146467467.e2
  • GrunfeldEAHunterMSSikkaPMittalSAdherence beliefs among breast cancer patients taking tamoxifenPatient Educ Couns20055919710216198223
  • LlewellynCDMcGurkMWeinmanJHead and neck cancer: to what extent can psychological factors explain differences between health-related quality of life and individual quality of life?Br J Oral Maxillofac Surg200544535135716105712
  • LlewellynCDMcGurkMWeinmanJThe Relationship Between the Patient Generated Index (PGI) and measures of HR-QoL following diagnosis with head and neck cancer: are illness and treatment perceptions determinants of judgment-based outcomes?Br J Health Psychol200712342143717726768
  • ManigatPGordenBRBreslowJLHow do we improve patient compliance and adherence to long-term statin therapy?Curr Atheroscler Rep201315129123225173
  • National Institute for Health and Care Excellence (NICE) Guidance [webpage on the Internet]Patient Experience in Adult NHS Services: Improving the Experience of Care for People Using Adult NHS ServicesNICE2012 Available from: https://www.nice.org.uk/guidance/cg138Accessed March 16, 2016
  • National Institute for Health and Care Excellence (NICE) Guidance [CG76] [webpage on the Internet]Medicines Adherence: Involving Patients in Decisions about Prescribed Medicines and Supporting Adherence2009 Available from: https://www.nice.org.uk/guidance/cg76Accessed March 16, 2016
  • CornerJBaileyCBCancer Nursing: Care in Context2nd edLondonBlackwells Publishing2008
  • Finnegan-JohnJThomasVJThe psychosocial experience of patients with end-stage renal disease and its impact on quality of life: findings from a needs assessment to shape a service ISRNNephrology2012201330898624959536
  • DiMatteoRMHaskard-ZolnierekKBMartinLRImproving patient adherence: a three-factor model to guide practiceHealth Psychol2012Rev 67491
  • NaikGAhmedHEdwardsACommunicating risk to patients and the publicBr J Gen Pract20126259721321622520906
  • DavidsonBVogelVWickerhamLOncologist-patient discussion of adjuvant hormonal therapy in breast cancer results of a linguistic study focusing on adherence and persistence to therapyJ Support Oncol20075313914317410813
  • BrownMTBussellJKMedication adherence: WHO cares?Rev Mayo Clin Proc2011864304314
  • CostaEGiardiniASavinMInterventional tools to improve medication adherence: review of literaturePatient Prefer Adherence201591303131426396502
  • FreemanGHughesJ homepage on the InternetContinuity of Care and the Patient ExperienceThe Kings Fund2010 Available from: https://www.kingsfund.org.uk/sites/default/files/field/field_document/continuity-care-patient-experience-gp-inquiry-research-paper-mar11.pdfAccessed March 5, 2016
  • BrookhartMAPatrickARSchneeweissSPhysician follow-up and provider continuity are associated with long-term medication adherence: a study of the dynamics of statin useArch Intern Med2007167884785217452550
  • Von BültzingslöwenIEliassonGSarvimäkiAMattssonBHjortdahlPPatients’ views on interpersonal continuity in primary care: a sense of security based on four core foundationsFam Prac200623210219
  • OsterbergLBlaschkeTAdherence to medicationN Engl J Med2005353548749716079372
  • FletcherCFlightIChapmanJFennellKWilsonCThe information needs of adult cancer survivors across the cancer continuum: a scoping reviewPatient Educ Couns2017100338341027765377
  • ZdenkowskiNForbesJFBoyleFMAustralia and New Zealand Breast Cancer Trials GroupObservation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptor-positive breast cancer (ANZ0501 LATER): an open-label randomised, controlled trialAnn Oncol201627580681226861603